New CFO Hire Will Strengthen LI-COR’s Leadership Team Lincoln, NE. LI-COR, a leading developer of environmental and biotech products, is pleased to announce the appointment of Jim Gould as its new Chief Financial Officer. Tom Reslewic, CEO of LI-COR, said “We’re very excited to have Jim on board. His depth of experience, knowledge, and management […]
Ion Torrent Oncomine Myeloid MRD Assays (RUO) are the first NGS-based tests to offer simultaneous DNA and RNA analysis for myeloid MRD assessment CARLSBAD, Calif., August 04, 2022 – Thermo Fisher Scientific today launched a next-generation sequencing (NGS)-based assay for research in myeloid measurable residual disease (MRD). As the first NGS-based tests to support both DNA […]
Company sharpens its focus on the European market by bolstering its team and building upon its successes with existing portfolio companies in Europe. Illumina Ventures, an independently-managed, healthcare-focused venture firm in a strategic partnership with Illumina, today announced the addition of four new members to its European team. Arnaud Autret, PhD, MSc, will be Principal and […]
CAMBRIDGE, England — Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution. Alistair Johnson is Chief Professional Services Officer at Congenica (Photo: Business Wire) Driven by the increasing adoption of […]
MINNEAPOLIS — Bio-Teche Corporation (NASDAQ: TECH) today announced Chuck Kummeth’s planned two-year transition from his position as Bio-Techne’s Chief Executive Officer (CEO) effective June 30, 2024. The Company’s Board of Directors has begun its search for Mr. Kummeth’s replacement, evaluating both internal and external candidates to assume the CEO position upon Kummeth’s retirement at the end of […]
– FDA EUA Variant Calling Assay Allows for Sequencing to Inform Patient Treatment – SOUTH SAN FRANCISCO, Calif. & NEW YORK — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Biotia, Inc., a company that uses proprietary analytical software for […]
REDWOOD CITY, Calif. and SAN DIEGO, Aug. 02, 2022 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced the execution of a Commercial License and Enzyme Supply Agreement, enabling Molecular Assemblies to utilize an […]
The company further expanded its commercial leadership team with the appointment of Jeff Bullard as Head of Sales for North America SAN DIEGO — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the appointment of Sam Ropp, Ph.D., as Chief […]
Novel CRISPR solution leverages Eclipse™ Platform to enable a faster path to therapeutic development REDWOOD CITY, Calif. – Synthego, the genome engineering company, today announced the launch of Engineered Cell Libraries, a novel offering that further enables access to CRISPR by providing arrayed CRISPR-edited cells for direct use in functional screening assays. The innovative solution leverages Synthego’s Eclipse™ […]
High-throughput sequencing methods mainly bases on Illumina platforms have benefited the entire field of biology for more than a decade. The opportunity to provide researchers with an unprecedented insight into the transcriptional landscape of cells by using RNA sequencing (RNA-seq) has boosted many important discoveries. However, RNA-seq is generally performed in bulk, which measures average […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
